Mitral Atresia Overview
Save information for later
Sign Up
Learn About Mitral Atresia
What is the definition of Mitral Atresia?
Mitral valve atresia is a rare congenital (present at birth) defect of the heart’s mitral valve. The mitral valve connects the heart’s left atrium (upper chamber) and left ventricle (lower chamber). In mitral valve atresia blood from the left atrium does not flow to the left ventricle, causing the left ventricle to become underdeveloped, while the body's blood is not properly oxygenated. Mitral valve atresia is often associated with other congenital heart defects, such as transposition of the great arteries, patent ductus arteriosus, and coarctation of the aorta, among others.
What are the symptoms of Mitral Atresia?
Symptoms of mitral valve atresia depend on its severity and any associated congenital heart defects and may include difficulty breathing; rapid breathing; bluish or gray skin, lips, or nails (cyanosis); pale, cool, or clammy skin; poor peripheral pulses; rapid heart rate; failure to thrive; and congestive heart failure.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Mitral Atresia?
Treatment for mitral valve atresia may include oxygen, mechanical ventilation, diuretics, vasopressors, antibiotics, shunts, and staged corrective surgeries.
Who are the top Mitral Atresia Local Doctors?
No local doctors have been found near Isabel, The United States. Expand the search radius or change your location here.
What are the latest Mitral Atresia Clinical Trials?
Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.
Who is this study for: Patients with Hypoplastic Left Heart Syndrome, Congential Heart Defects
Enrollment Status: Recruiting
Publish Date: May 06, 2024
Intervention Type: Combination product
Study Drug: Tissue Engineered Vascular Grafts
Study Phase: Phase 2
Summary: A single arm clinical trial evaluating the safety and efficacy of the second generation TEVG as vascular conduits for extracardiac total cavopulmonary connection.
What are the Latest Advances for Mitral Atresia?
Successful repair of infracardiac total anomalous pulmonary venous connection with nonconfluent bilateral pulmonary veins.
Journal: Asian cardiovascular & thoracic annals
Published: October 18, 2024
Dual Decompression of the Left Atrium in Mitral Atresia With Intact Atrial Septum.
Journal: World journal for pediatric & congenital heart surgery
Published: August 29, 2024
Tired of the same old research?
Check Latest Advances
Clinical Presentation and Therapy of Hypoplastic Left Heart Syndrome.
Journal: Advances in experimental medicine and biology
Published: June 17, 2024